Medicine and Dentistry
Patient
100%
Diagnosis
51%
Therapeutic Procedure
41%
Migraine
40%
Pulse Rate
29%
Transcranial Magnetic Stimulation
29%
Experience
27%
Symptom
25%
Trigeminal Autonomic Cephalalgia
25%
Treatment Response
25%
Transformed Migraine
25%
Shock (Circulatory)
25%
Orofacial Pain
25%
Episodic Migraine
25%
Erenumab
25%
Snow
25%
Syndrome
25%
Idiopathic Intracranial Hypertension
25%
Optical Coherence Tomography
25%
Systematic Review
25%
Cluster Headache
25%
Nerve Block
25%
Adverse Event
21%
Prophylaxis
20%
Headache
19%
Neuroimaging
16%
Drug Therapy
14%
Follow up
13%
Primary Headache
11%
Disease
10%
Anodyne
10%
Time to Treatment
10%
Case Report
10%
Non Invasive Procedure
8%
Papilledema
8%
Element
8%
Optic Nerve Atrophy
8%
Intracranial Pressure
8%
Retinal Nerve Fiber Layer
8%
Retina
8%
Brain Imaging
8%
Mechanism of Action
8%
Benzodiazepine
7%
Calcitonin Gene Related Peptide
6%
Clinical Trial
6%
Tertiary Care
6%
Female
6%
Therapeutics
6%
Neurology
5%
Hemicrania Continua
5%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
59%
Calcitonin Gene Related Peptide Receptor Antagonist
56%
Receptor Agonist
23%
Hepatotoxicity
18%
Tolerability
12%
Cardiovascular Disease
10%
Drug-Drug Interaction
5%
Preclinical Study
5%
Controlled Clinical Trial
5%